Feed PAVM
PA

PAVmed Inc.

PAVM · NASDAQ

$4.19 -4.34% (-$0.19)
1M -17.64%
Market Cap $26.7M
P/E Ratio -
Div. Yield -
ROE 33.51%

Bulios Fair Price

$5.72

36.5% upside

Trenutna cena

$4.19

Podcenjeno Poštena vrednost Precenjeno

Po podatkih Bulios Fair Price je delnica PAVM trenutno podcenjena glede na svojo tržno ceno. Kako deluje?

Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?

Piotroski F-Score Weak
2/9
Valuation
50 /100
Fair
P/B 0.76x
P/S 238.80x
EV/EBITDA N/A
Growth
0 /100
Declining
Rev. growth 42.68%
FCF growth N/A
Book val. growth N/A
Profitability
0 /100
Weak
Net margin 10,794.60%
Op. margin 23,842.90%
FCF margin 2,343,880.00%
Quality
0 /100
Poor
ROE 33.51%
ROA 30.06%
Asset turnover 0.00x
Debt
50 /100
Moderate
Current ratio 1.19x
Int. coverage -958.56x
Debt/Equity 0.49x
Stability
27 /100
Unstable
Rev. volatility 344.80%
EPS volatility 125.73%
Profitable years 2

Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več

Vprašajte StockBota o PAVM
Online

O podjetju

PAVmed Inc. (PAVM) is an American company focused on innovation in the field of healthcare technologies. The company specializes in the development and commercialization of medical devices and technologies with the potential to improve diagnostics and treatment of various medical conditions. PAVmed focuses on creating patented products and technologies that have the potential to transform the way certain medical procedures are performed. With its innovative approach, PAVmed can attract investors seeking opportunities in healthcare innovation and advanced medical technologies. Shares of PAVmed Inc. (PAVM) could present an intriguing investment opportunity.

V vašem jeziku še ni na voljo, zato je besedilo v angleščini.

Sector

Healthcare

Industry

Medical - Devices

CEO

Lishan Aklog

Employees

41

Headquarters

New York City

Prihajajoči dogodki

12 NOV.

Earnings

Upcoming earnings report

58d

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe. Preberite naš Pravilnik o zasebnosti.